Roche underscores its long-term commitment to Taiwan’s Healthy Taiwan vision through sustained R&D investment, clinical trials, and real-world data supporting precision medicine. By advancing patient access and advocating for value-based healthcare, Roche aims to help Taiwan build a more innovation-friendly and sustainable biomedical ecosystem.

In an industry as dynamic and competitive as healthcare, standing out requires outstanding ingenuity, while still maintaining a dedication to patient wellbeing and care. For California-headquartered biopharmaceutical company Amgen, which last year celebrated 40 years of providing innovative and life-changing treatments to patients, being a leader is baked into its DNA. Over that period, 70%…